Mifepristone Access Swings In The Balance In Post-Roe World

30 Million US Women Of Reproductive Age Have Now Lost Abortion Access

The US Supreme Court has overturned Roe v. Wade, but numerous avenues could help to preserve access to abortion drug mifepristone – if legislators and lawmakers are willing to walk down them.

Protestor holding a sign reading 'Abortion is healthcare'
Around 40% of reproductive-age women in the US have now lost access to abortion care • Source: Shutterstock

More from Market Access

More from In Vivo